Evidence map›Paper›PMID 35000896›Full record

ArticleJournal of the Turkish German Gynecological Association2022

Brenner tumors of the ovary: clinical features and outcomes in a single-center cohort

Dilek Yüksel, Ciğdem Kılıç, Caner Çakır, Günsu Kimyon Cömert, Taner Turan, Eylem Ünlübilgin, Nurettin Boran, Fulya Kayıkçıoğlu, Sevgi Koç

Open access · diamondAbstract read
In one paragraph

Article in Journal of the Turkish German Gynecological Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Brenner tumors of the ovary: A case series in a teaching institute center.Journal of family medicine and primary care · 2023
    Article
  9. A Rare Case of Ruptured Malignant Ovarian Brenner Tumor.The American journal of case reports · 2023
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Dilek YükselClinic of Gynecologic Oncology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women’s Health Teaching and Research Hospital, Ankara, TurkeyORCID 0000-0002-2366-8412
Ciğdem KılıçClinic of Gynecologic Oncology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women’s Health Teaching and Research Hospital, Ankara, TurkeyORCID 0000-0002-4433-8068
Caner ÇakırClinic of Gynecologic Oncology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women’s Health Teaching and Research Hospital, Ankara, TurkeyORCID 0000-0003-2559-9104
Günsu Kimyon CömertClinic of Gynecologic Oncology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women’s Health Teaching and Research Hospital, Ankara, TurkeyORCID 0000-0003-0178-4196
Taner TuranClinic of Gynecologic Oncology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women’s Health Teaching and Research Hospital, Ankara, TurkeyORCID 0000-0001-8120-1143
Eylem ÜnlübilginClinic of Gynecology and Obstetrics, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women’s Health Teaching and Research Hospital, Ankara, TurkeyORCID 0000-0002-1529-2523
Nurettin BoranClinic of Gynecologic Oncology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women’s Health Teaching and Research Hospital, Ankara, TurkeyORCID 0000-0002-0367-5551
Fulya KayıkçıoğluClinic of Gynecologic Oncology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women’s Health Teaching and Research Hospital, Ankara, TurkeyORCID 0000-0002-1078-0982
Sevgi KoçClinic of Gynecologic Oncology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women’s Health Teaching and Research Hospital, Ankara, TurkeyORCID 0000-0002-1703-0690
Zübeyde Hanim Maternity Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe purpose of the present study was to evaluate the clinical and pathological features and oncological outcomes of Brenner tumors (BT). MATERIAL AND

methodsEvaluation was performed on the data of 46 patients with BTs retrieved from the oncology clinic database and pathology reports between 2005 and 2020.

resultsThe median (range) age of the patients was 52 (22-75) years. Median (range) tumor size was 52.5 (5.0-300) mm. The tumor was benign in 37 (80.4%), borderline in one (2.2%), and malignant in the remaining eight (17.4%). Ten (21.7%) of the tumors were detected incidentally. Mixed tumor, BT plus another ovarian pathology, was found in 13 (28.2%). Recurrence developed in 2/8 (25%) with malignant BT (MBT). The stage of these patients was 3C, and both received chemotherapy after surgery.

conclusionBTs are rare and generally detected incidentally. MBTs are treated in the same way as epithelial tumors. Due to the rarity of these tumors, lymphadenectomy and optimal chemotherapy regimens are controversial issues.

Indexed as

Brenner tumors of the ovarymalignant Brenner tumorsmixed tumorsrare tumors

Identifiers

PMID35000896
PMCPMC8907439
OpenAlexW4206690126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.